Pacira BioSciences, Inc.
PCRX
Price:
$17.55
Market Cap:
$810.34M
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira Bi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-02-03
Stock Exchange
NASDAQ
Ticker
PCRX
PE Ratio
[-8.86]
ROE
[-10.70%]
Current Ratio
[2.25]
Dividend Yield
[0%]
Enterprise Value
[1.21B]
Dividend History
The ROE as of November 2024 (TTM) for Pacira BioSciences, Inc. (PCRX) is -10.70%
According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -10.70%. This represents a change of 226.11% compared to the average of -3.28% of the last 4 quarters.
Pacira BioSciences, Inc. (PCRX) Historical ROE (quarterly & annually)
How has PCRX ROE performed in the past?
The mean historical ROE of Pacira BioSciences, Inc. over the last ten years is -0.69%. The current -10.70% ROE has changed 1.45% with respect to the historical average. Over the past ten years (40 quarters), PCRX's ROE was at its highest in in the September 2020 quarter at 22.25%. The ROE was at its lowest in in the September 2024 quarter at -19.14%.
Average
-0.69%
Median
0.35%
Minimum
-17.33%
Maximum
23.48%
Pacira BioSciences, Inc. (PCRX) ROE by Quarter and Year
Discovering the peaks and valleys of Pacira BioSciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.02%
Maximum Annual ROE = 23.48%
Minimum Annual Increase = -2139.21%
Minimum Annual ROE = -17.33%
| Year | ROE | Change |
|---|---|---|
| 2023 | 4.82% | 134.89% |
| 2022 | 2.05% | -64.28% |
| 2021 | 5.75% | -75.53% |
| 2020 | 23.48% | -856.65% |
| 2019 | -3.10% | 2.02% |
| 2018 | -0.15% | -99.04% |
| 2017 | -15.25% | -12.02% |
| 2016 | -17.33% | -2139.21% |
| 2015 | 0.85% | -110.60% |
| 2014 | -8.01% | -94.83% |
Pacira BioSciences, Inc. (PCRX) Average ROE
How has PCRX ROE performed in the past?
The current ROE of Pacira BioSciences, Inc. (PCRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
4.21%
5-year avg
6.60%
10-year avg
-0.69%
Pacira BioSciences, Inc. (PCRX) ROE vs. Peers
How is PCRX’s ROE compared to its peers?
Pacira BioSciences, Inc.’s ROE is less than Phibro Animal Health Corporation (6.59%), less than Dr. Reddy's Laboratories Limited (18.58%), less than Collegium Pharmaceutical, Inc. (40.81%), less than Silver Spike Investment Corp. (5.74%), less than Prestige Consumer Healthcare Inc. (12.35%), greater than HUTCHMED (China) Limited (-5.71%), greater than Incannex Healthcare Limited (-73.90%), less than Eagle Pharmaceuticals, Inc. (17.39%), greater than ANI Pharmaceuticals, Inc. (-1.60%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than Intra-Cellular Therapies, Inc. (-9.93%), less than Alkermes plc (26.49%),
| Company | ROE | Market cap |
|---|---|---|
| 6.59% | $961.56M | |
| 18.58% | $11.84B | |
| 40.81% | $966.22M | |
| 5.74% | $66.72M | |
| 12.35% | $4.19B | |
| -5.71% | $3.03B | |
| -73.90% | $34.94M | |
| 17.39% | $12.31M | |
| -1.60% | $1.20B | |
| -52.42% | $2.21B | |
| -9.93% | $9.08B | |
| 26.49% | $4.66B |
Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pacira BioSciences, Inc.'s ROE?
How is the ROE calculated for Pacira BioSciences, Inc. (PCRX)?
What is the highest ROE for Pacira BioSciences, Inc. (PCRX)?
What is the 3-year average ROE for Pacira BioSciences, Inc. (PCRX)?
What is the 5-year average ROE for Pacira BioSciences, Inc. (PCRX)?
How does the current ROE for Pacira BioSciences, Inc. (PCRX) compare to its historical average?